Philadelphia chromosome-positive acute lymphoblastic leukaemia in children (Ph-positive ALL)

What changed: Philadelphia chromosome-positive acute lymphoblastic leukaemia in children (Ph-positive ALL)

Every dated change on the records linked to Philadelphia chromosome-positive acute lymphoblastic leukaemia in children (Ph-positive ALL), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Trial result3Milestone7This record1On Edge

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordPhiladelphia chromosome-positive acute lymphoblastic leukaemia in children (Ph-positive ALL)
Facts on this page last checked
When this page itself was last checked or edited.

2024 · 2

2020 · 2

2018 · 2

2013 · 1

2013MilestoneImatinib
Imatinib approved for children with newly diagnosed Ph-positive ALL
A milestone in how this cancer is treated.

2009 · 1

2009MilestoneImatinib
AALL0031: continuous imatinib with chemotherapy gives 80 percent three-year event-free survival
A milestone in how this cancer is treated.

2001 · 1

2001MilestoneImatinib
Imatinib approved for chronic myeloid leukaemia
A milestone in how this cancer is treated.

1960 · 1

1960MilestonePhiladelphia chromosome (Ph+, BCR::ABL1)
Nowell and Hungerford describe the Philadelphia chromosome
A milestone in how this cancer is treated.